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Placental Transfer of Cadmium in
Rats: Influence of Dose and
Gestational Age
by B. R. Sonawane,* M. Nordberg,t G. F. Nordberg,t and
G. W. Lucier*
Placental transfer rates ofcadmium were investigated in rats in relation to dose (0.1, 0.4,
and 1.6 mg Cd/kg} and the gestational age (12, 15, and 20 days) when rats were treated.
Pregnant rats were injected intravenusly with a single dose of lD9CdCl2 (- 20 ,Ci/animal),
and animals were sacrificed after 24 hr. l09Cd concentrations were measured in the fetus,
placenta, maternal liver, andd blood.
Cadmium crossed the placenta at all doses and at all gestational ages tested. However,
higher percentages of administered cadmium accumulated in the fetus with increasing
dose and increasing gestational age. For example, after pregnant rats were injected with
low, middle, and high doses ofCd an day 12ofgestation, fetuses accumulated 0.0001, 0.0028,
and 0.0095% of the injected dose, respectively. Percentages ofadministered Cd detected in
placental tissue did not change consistently with dose but Cd levels did increase with
gestational age. Placental to-maternal blood Cd concentration ratios increased with gesta-
tional age but not with dose. Maternral liver to fetal liver concentration ratios were 295, 137,
and 27 for the low, middle anid high doses, respectively, 24 hr after pregnant rats were
treated on day 20Ofgestation. These results are discussed in relation to placental damage,
metallothionein inducibility, and fetotoxicity.
Introduction
Recently cadmium has been recognized to be a
highly toxic environmental contaminant. Effects
such as renal dysfunction and hypertension have
been reported following long-term exposure (1,2).
After injection of cadmium to experimental
animals, fetotoxicity and teratogenicity were ob-
served as well as necrotic changes in testicles and
sensory ganglia. Reproductive effects and effects on
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the offspring have also been found following long-
term oral exposure ofanimals to cadmium (3). It is
not known, however, whether the effects on the
offspring seen in long-term exposures or those seen
in acute exposures to cadmium are related to direct
effects of cadmium transferred through the
placenta.
Previous studies ofFerm et al. (4) demonstrated
placental transfer of cadmium in hamsters after
single intravenous administration of 0.50 or 0.85
mg Cd/kg on day 8 ofgestation. On the other hand,
Berlin and Ullberg (5), using an autoradiographic
technique, did not detect placental cadmium
transfer. Since it is well known that placental
morphology and permeability characteristics
change markedly during development, we at-
tempted to elucidate the factors that regulate and
December 1975 97influence placental transfer of heavy metals.
Studies reported here were designed to give infor-
mation regarding placental uptake and placental
transfer of l09Cd injected intravenously in the rat
at various gestational times and after different
doses.
Materials and Methods
Animals
Date-bred rats (Charles River, CD strain,
90-120 days old) were used. Fetal age was deter-
mined by designating the sperm positive date as
day 0. The animals were housed singly in polycar-
bonate cages in an environment of controlled tem-
perature (22 ± 1°C) and humidity (50 ± 10% ), and
they received tap water and Wayne Sterilizable
Lab-Blox food ad libitum. Carrier-free lO9Cd as
CdCl2 in 0.5N HCl was obtained from New Eng-
land Nuclear, Boston, Massachusetts. Injection
solutions were prepared by dissolving CdCL2 in
saline (0.09% ) and mixing with the LO9CdCl2 solu-
tion to obtain desired concentrations. Solutions
were neutralized with 0.1N NaOH. Doses used were
0.1, 0.4, and 1.6 mg Cd/kg ofbody weight, and each
rat was injected intravenously with 15-20 ACi of
l09Cd via the tail vein on day 12, 15, or 20 of gesta-
tion. Volumes were approximately 0.1 ml/100 g of
body weight. Dose-response experiments were so
designed that no embryotoxicity or teratogenicity
was observed at the low dose whereas these effects
were evident after pregnant animals received the
high dose.
Tissue Analysis
Animals were anesthesized 24 hr after injection,
and maternal whole blood was withdrawn by car-
diac puncture. Part of the maternal livers, whole
placentas, and whole fetuses were removed and
placed in previously weighed plastic test tubes for
gamma counting (Packard Instrument Co., Inc.,
Downers Grove, Illinois). Placentas and fetuses
were washed immediately in saline, blotted with
paper, and placed in gamma counting tubes. Fetal
livers from animals treated on day 20 of gestation
were removed, and livers from each litter were
pooled. After removal of livers, individual fetuses
were counted. Radioactivity measurements were
performed in a Packard Autogamma scintillation
counting system (6).
An attempt was made to assess placental func-
tion by using enzyme markers in animals treated
with cadmium on day 20 ofgestation. At 24 hr after
treatment, placental cytosol (105,000g superna-
tant) was assayed for cystine aminopeptidase (7)
and arylsulfatase A and B (8); L-cystine
bisnitroanilide and 2-hydroxy-5-nitrophenyl sul-
fate, respectively, being used as substrates. Activity
ofserum heat-stable alkaline phosphatase was also
measured by usingp-nitrophenyl phosphate as the
substrate (9).
Statistical Analysis
The significance ofthe results in relation to dose
or gestational day was determined by Jonckheere's
test (10). The values represent the mean ± stan-
dard deviation unless otherwise mentioned.
Results
Cadmium levels in maternal liver and maternal
whole blood 24 hr after injection expressed as per
cent of injected dose per gram of wet tissue are
shown in Table 1. Liver values were consistently
morethan 100 times the blood values, which agrees
with literaturevalues (4). No significant differences
in relation to dose or day of gestation were ob-
served.
Percentages of injected dose of l09Cd detected in
placentas at various dose levels and gestational
ages are illustrated in Figure 1. The Cd levels did
not change consistently in relation to dose.
However, significant (p< 0.01) gestational day
differences were found for placental Cd levels for
all three doses (Fig. 1). For example, the low dose
treatment resulted in 0.10, 3.15, and 7.59% of the
injected dose of l09Cd in placentas after injection
on day 12, 15, or 20 of gestation, respectively. The
gestational day relationship (statistically signifi-
cant atp < 0.01) was still evident in some cases
when data were expressed as,tg Cd/gram ofplacen-
tal tissue (Table 2). When data are calculated on a
concentration basis, changes in tissue size do not
influence the results.
Preliminary studies on placental function
enzymes after Cd treatment on day 20 of gestation
were not conclusive with no significant changes
from control values. Enzymestested wereplacental
L-cystine aminopeptidase, arylsulfatases A and B
and serum heat-stable alkaline phosphatase.
Percentages ofinjected doses of l09Cd detected in
fetuses 24 hr after treatment at different dose levels
Environmental Health PerspectivesTable 1. Cd in rat maternal liver and blood.a
Cd, %, /g ofinjected dose1)
Dose, Gestation Gestation Gestation
mg/kg day 12 day 15 day 20
Liver 0.1 (7) 2.9 ± 0.5 (5) 4.7 ± 1.2 (3) 5.1 ± 0.4
0.4 (6) 4.7 ± 0.5 (3) 4.4 ± 0.6 (3) 4.7 ± 0.8c
1.6 (7) 3.0 ± 0.6 (3) 3.3 ± 1.2 (3) 3.4 + 0.3c
Blood 0.1 (6) 0.010 ± 0.015 (3) 0.017 ± 0.002 (4) 0.011 + 0.002
0.4 (7) 0.020 ± 0.009c (3) 0.022 ± 0.006 (3) 0.019 ± 0.008
1.6 (8) 0.022 ± 0.008c (4) 0.017 ± 0.002 (3) 0.013 ± 0.004
aRatssacrificed 24 hrs after Cd treatment atvarious dose levels.
bValues in parentheses refer to numbers ofanimals.
cSignificantly different from 0.1 mg/kg dose level,p <0.05.
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FIGURE 1. Percentage of injected l09Cd detected in placentas
for each dose and gestational day.
and gestational day periods are shown in Figure 2.
The last bar graph represents the percentage of in-
jected dose of l09Cd in fetal rat livers treated on
day 20 gestation. Fetal cadmium levels exhibited
significant (p <0.01) dose and gestational day rela-
tionships. Higher percentages of administered Cd
were found in the fetuses with increasing dose and
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each dose and gestational day.
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99Table 2. Cd in placentas and fetuses.a
Cd, % /gofinjected doseb
Dose, Gestation Gestation Gestation
mg/kg day 12 day 15 day 20
Placentase 0.1 0.063 ± 0.043 0.0115 ± 0.049 1.403 ± 0.293
(1.6) (5.8) (5.6)
0.4 0.232 ± 0.032c 0.142 ± 0(.024 1.347 60.127
(1.6) (4.7) (5.8)
1.6 0.206 ± 0.057c 0.466 ± 0.147d 0.587 0.167
(1.3) (3.8) (6.9)
Fetusesf 0.1 0.00012 ± 0.00004 0.0014 ± 0.0001 0.0019 ± 0.0003
(1.1) (6.8) (64.7)
0.4 0.0022 ± 0.0023 0.0027 ± (.oold 0.00364 0.0016
(1.1) (7.6) (69.1)
1.6 0.0217 ± 0. 0.0096 ± 0.0026 0.0152 ) 0.0058
(0.9) (4.9) (50.8)
'Rats sacrificed 24 hr after Cd treatment atvarious dose levels.
bNumbers in parentheses indicates average weight ofplacentas per litter or average fetal weight per litter. At least three pregnant
animals were used to obtain each value.
cSignificantly different from 0.1 mg/kg dose level,p <0.05.
dSignificantly differentfrom0.1 mg/kg doselevel,p <0.01.
eThe dose-response test for placental data revealed significant dose-response relationships for the day 12 and day 15 groups and
significant gestational day relationships at the 0.1 and 1.6 doses at least atp < 0.05.
fThe dose-response test for fetal data revealed significant dose-response relationships for all gestational groups and significant
gestational day differences at the 0.1 dose at least atp < 0.01.
increasing gestational age. For example, after preg-
nant rats were injected with low, middle, and high
doses ofCd at day 12 ofgestation, fetuses accumul-
ated 0.0001, 0.003, and 0.009% ofthe injected dose,
respectively (Fig. 2), representing a 90-fold increase
in the percentage ofcadmium detected in fetuses in
the high dose compared to low dose. Fetal con-
centrations of Cd expressed as per cent of injected
dose/gram are presented in Table 2. Significant
gestational age relationships were observed when
data were calculated as percentage of injected
dose/gram (Table 2). For example, levels found in
fetuses from animals treated with the low dose on
day 20 of gestation were ten times those treated on
day 12.
Attempts were made to assess possible
differences in Cd uptake between fetuses dissected
from right and left uterine horns or in individual
fetuses from proximal or distal ends of the uterus.
Although considerable variations were observed,
no significant differences were found. The fetuses
from the high dose treatment exhibited edema, hy-
peremia and some of them were found dead. For
example, high dose treatment on day 20 of gesta-
tion resulted in 14 dead fetuses out of 36. In other
studies, when animals were treated on day 12 of
gestation with 1.6 mg Cd/kg and sacrificed on day
21, teratogenic effects like cleft palate (2% ), club
foot (4% ), and micrognathia (4% ) were observed
(51 fetuses were observed). No such effects were
detected in a corresponding number of animals
receiving 0.1 or 0.4 mg Cd/kg.
In order to illustrate placental transfer rates of
Cd the ratio of percentage of administered
dose/gram tissue found in placenta to that detected
in fetuses is presented in Table 3. Cadmium crossed
the placenta at all gestational ages tested. The
ratios clearly demonstrate some significant dose
and gestational day relationships. In all groups
there was more Cd in placentas than in fetuses. In
general, placental:fetal ratios decreased with in-
creasing dose and increasing gestational age on
treatment. However, values were inconsistent for
the high dose.
Table 4 shows the concentration of Cd in rat
fetal liver following treatment on day 20 of gesta-
tion. Cd levels, as expected, increased in fetal liver
with increasing dose levels. Percentages of fetal
liver Cd ofmaternal liver levels exhibited a highly
significant (p< 0.01) dose relationship with in-
creasing percentages found in fetal livers with in-
creasing dose. Fetal liver Cd levels account for ap-
proximately 50% of whole fetal Cd levels indicat-
ing that liver is the major Cd accumulation site in
rat fetuses.
Maternal blood Cd is transported to the placen-
ta where it may be bound and/or transferred to the
fetus. Our data reveal that placenta to maternal
blood concentration ratios increase with increasing
gestational age for each dose tested (Table 5).
Environmental Health Perspectives 100Table 3. Placental to fetal Cd concentration ratios.a
Ratio placental: fetal Cd
Dose, Gestation Gestation Gestation
mg/kg per day day 12 day 15 day 20
0.1c 618.00 ± 409.11 103.94 ± 29.28 78.877 ± 32.248
0.4 266.11 ± 232.92b 55.92 ± 17.41 41.852 ± 16.786
1.6 11.23 ± 4.16b 56.64 ± 7.56 42.69 ± 2.244b
aRatios are based on percentage ofinjected dose/g found in placentas and fetuses.
bSignificantlydifferent from 0.1 mg/kg dose level, p <0.01.
'The dose-response test revealed significant dose-response relationships for the day 12 and day 15 groups at least atp < 0.01.
Table 4. Cd levels in rat fetal liver following treatment on day 20 ofgestation.a
Cd level
Dose, Fetal liver, % of maternal % of whole
mg/kg ,g/g liver fetus
0.1'' 0.047 + 0.011 0.22 ± 0.03 46.21 ± 6.89
0.4 0.092 0.058 0.53 ± 0.26" 49.69 ± 4.53
1.6 0.540 0.200b 2.93 ± 0.89b 57.77 ± 4.58
aRats sacrificed 24 hr after treatment atvarious dose levels. Three pregnant animals used to obtain eachvalue. bSignificantly different from 0.1 mg/kg dose level at least atp < 0.01.
'The dose-response test revealed significant dose-response relationships for fetal liver cadium concentrations and percentages of
maternal liver at least atp < 0.01.
Table 5. Placental to maternal blood concentration ratios.a
Ratio placental: maternal blood Cd
Dose, Gestation Gestation Gestation
mg/kg day 12 day 15 day 20
0.1dl 14.9 ± 3.0 37.9 ± 7.8b 118.8 + 47 7b,c
0.4 12.3 ± 6.4 26.8 ± 4.5b 58.7 + 17 2b,c
1.6 11.8 ± 7.9 25.9 ± 8.8b 52.5 + 36.3b,C
aRatio ofpercentage ofinjected dose/g ofplacentas to percentage ofinjected dose/g ofmaternal whole blood.
bSignificantly different from the 12th daytreatment,p <0.01.
CSignificantly different from 0.1 mg/kg dose level,p <0.05.
"1The dose-response test revealed significant gestational day differences for all doses at least atp < 0.05.
Discussion
Our data have demonstrated that the placental
transfer rates of Cd increase with increasing gesta-
tional age. Maternal liver to fetal Cd percentages of
injected dose range from about 500 in the low dose
day 20 group to approximately 30 in the high dose
day 20 group. In addition to the gestational age in-
fluence, dose effects were ascertained in the present
studies. Previous studies by Ferm et al. (4) have
shown that hamster placenta is permeable to Cd in-
jected on day 8 of gestation. They suggested that
the placental membranes might block the transfer
of Cd as the placenta differentiates and matures.
This contrasts with our studies and might reflect
species differences and age differences. The large
concentration gradient between maternal and fetal
tissues in our studies might explain why Berlin and
Ullberg (5) could not detect fetal Cd in their
autoradiographic studies. Previous studies (11)
have also shown that Cd crosses the placenta in
mouse strains whether they are sensitive or resis-
tant to Cd teratogenicity after treatment on day 10
of gestation.
It is interesting to note that fetotoxicity and
teratogenicity are observed after injection of the
high dose at day 12 of gestation, when Cd levels in
fetal and placental tissues are as low as 0.06 and
December .1975 1011.22 pgg/g, respectively. These levels are similar to
Cd levels after treatment at later gestational times
when no fetotoxicity was observed, indicating
greater fetal sensitivity to Cd toxicity at early
developmental stages.
No correlation between placental function
enzyme activities and placental transfer of Cd
could be demonstrated. However, further studies
are needed to clarify whether placental damage
might influence the dose and gestational age rela-
tionships reported in this study.
In conclusion, our studies demonstrate that Cd
injected intravenously passes the placenta and is
detected in rat fetuses. The ratios of placental to
fetal Cd concentrations decrease with increasing
dose, and fetal percentages of injected dose/gram
increase at later gestational ages as well as with
dose.
A hypothetical explanation for these phenomena
may be offered. It is known that an increase in Cd
bodyburden initiates the biosynthesis ofa Cd-bind-
ing protein-metallothionein (12). The ability of
maternal tissues and placenta to bind cadmium
and the inducibility rates of metal-binding protein
in these tissues might be important factors in pla-
cental transfer. More cadmium might enter the
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